Patient Square Capital’s Liquidia Corp LQDA Stock Holding History

Patient Square Capital’s Portfolio LQDA Stock Details LQDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-227,000	Closed	-$7.83M	–	33
2025 Q4	$7.83M	Sell	227,000 -173,000	-43%	-$4.93M	1.68%	13
2025 Q3	$9.1M	Sell	400,000 -620,000	-61%	-$13.4M	2.43%	7
2025 Q2	$12.7M	Sell	1,020,000 -502,452	-33%	-$7.44M	4.58%	5
2025 Q1	$22.5M	Sell	1,522,452 -337,919	-18%	-$4.93M	9.29%	3
2024 Q4	$21.9M	Sell	1,860,371 -5,322,161	-74%	-$58.2M	8.18%	2
2024 Q3	$71.8M	Hold	7,182,532	–	–	26.66%	2
2024 Q2	$86.2M	Hold	7,182,532	–	–	40.01%	2
2024 Q1	$106M	Buy	+7,182,532	New	+$99.9M	45.11%	2

Other funds holding LQDA

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Findell Capital Management New York $341M AUM 135.6% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Patient Square Capital's LQDA Position: Q1 2026 in Review

Patient Square Capital sold out of Liquidia Corp (LQDA) in Q1 2026, closing a stake of 227,000 shares — an estimated $7.83M sold.

Patient Square Capital first reported a position in LQDA in Q1 2024 and held it in 8 quarters. The position peaked at $106M in Q1 2024. 244 funds tracked by Wall St. Rank hold LQDA as of Q1 2026.

Patient Square Capital reported no remaining Liquidia Corp position as of Q1 2026 after selling out during the quarter.
Patient Square Capital sold 227,000 Liquidia Corp shares in Q1 2026, an estimated $7.83M.
Patient Square Capital first reported a position in Liquidia Corp in Q1 2024 and held it in 8 quarters.
Patient Square Capital's Liquidia Corp position peaked at $106M in Q1 2024.
244 funds tracked by Wall St. Rank held Liquidia Corp as of Q1 2026.

Based on Patient Square Capital's 13F filing for Q1 2026, filed 15 May 2026.